Delgado-Lara et al. reported increased BMAL1 gene expression in PD patients who were administered 25 mg of melatonin for 3 months, particularly in the morning, suggesting the improvement in PD symptom management is linked to restoration of core-clock machinery108. This evidence concerns the gene BMAL1 and Parkinson disease.